Home › Funds › Sio Capital Management, LLC › ANIP

Sio Capital Management, LLC position in ANIP

ANI PHARMACEUTICALS INC · Health Care

Sio Capital Management, LLC reported holding 97,305 shares of ANIP (ANI PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$8.1M, representing 1.33% of its reported portfolio and ranking #28 among its reported holdings. Sio Capital Management, LLC has disclosed ANIP holdings in 9 of the last 10 reported quarters, going back to Q1 2024.

Latest position (Q2 2026)97.31K sh
Reported value held$8.05M
Portfolio Weight1.33%
First reportedQ1 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Sio Capital Management, LLC's ANIP position evolved

Sio Capital Management, LLC first disclosed a stake in ANIP in Q1 2024 at 87,354 shares (US$6.0M). The position peaked in Q1 2026 at 265,543 shares, worth US$20.4M. Across 9 filings, Sio Capital Management, LLC increased the stake 3 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 97,305 shares valued at US$8.1M — a reduction of -168,238 shares quarter over quarter.. Notable position changes include a 57% increase in Q4 2025 (shares fell 3% over the following quarter), a 204% increase in Q1 2026 (shares rose 8% over the following quarter), a 63% trim in Q2 2026 (shares fell 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 87.35K $6.04M New
Q2 2024 71.74K $4.57M Reduce
Q4 2024 160.05K $8.85M New
Q1 2025 87.30K $5.84M Reduce
Q2 2025 112.92K $7.37M Add
Q3 2025 55.72K $5.10M Reduce
Q4 2025 87.27K $6.89M Add
Q1 2026 265.54K $20.42M Add
Q2 2026 97.31K $8.05M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ANIP and 13F data

ANIP (ANI PHARMACEUTICALS INC) is a Health Care company. 49 other funds we track also report a position in ANIP — the largest reported positions include Soleus Capital Management, L.P. (US$71.8M), TANG CAPITAL MANAGEMENT LLC (US$58.6M), Global Alpha Capital Management Ltd. (US$46.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ANIP

All ANIP fund holders →

FAQ

How long has Sio Capital Management, LLC held ANIP?

Sio Capital Management, LLC has disclosed ANIP holdings in 9 of the last 10 reported quarters, going back to Q1 2024.

What is Sio Capital Management, LLC's current position in ANIP?

As of Q2 2026, Sio Capital Management, LLC holds 97.31K shares of ANIP (ANI PHARMACEUTICALS INC), valued at $8.05M, representing 1.33% of its reported portfolio and ranking #28.

Has Sio Capital Management, LLC been buying or selling ANIP?

In the latest 13F filing (Q2 2026), Sio Capital Management, LLC reduced its position in ANIP. The position peaked in Q1 2026 at 265.54K shares.

Which other funds hold ANIP?

Other major institutional holders of ANIP include Soleus Capital Management, L.P., TANG CAPITAL MANAGEMENT LLC, Global Alpha Capital Management Ltd., among 49 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.